The HBB gene encodes the β-globin protein, a component of adult hemoglobin A (HbA) which is responsible for the transportation of oxygen. Mutations in the HBB gene can impair β-globin synthesis and disrupt hemoglobin production. Patients who possess both a protein-reducing β-thalassemia mutation and a β<sup>E</sup> mutation in their HBB gene are affected by hemoglobin E/β-thalassemia disease. This study demonstrates the successful generation and characterization of the human pluripotent stem cell (hiPSC) line MURAi002-A derived from a patient with hemoglobin E/β<sup>0</sup>-thalassemia disease harboring the specific codon 41/42 (−CTTT) β<sup>0</sup>-thalassemia mutation through the utilization of non-integrative reprogramming episomes.
